{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:22:39Z","timestamp":1782235359685,"version":"3.54.5"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuropharm.2026.110856","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:02:34Z","timestamp":1769875354000},"page":"110856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of a novel IMS48 as a dual inhibitor of acetylcholinesterase and butyrylcholinesterase: In vitro and in vivo study for Alzheimer therapy"],"prefix":"10.1016","volume":"289","author":[{"given":"Samman","family":"Munir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunera","family":"Chauhdary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matloob","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3196-2857","authenticated-orcid":false,"given":"Mohsin","family":"Khurshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-805X","authenticated-orcid":false,"given":"Usman Ali","family":"Ashfaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110856_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24050861","article-title":"Synthesis and AChE-Inhibitory activity of new benzimidazole derivatives","author":"Acar Cevik","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.110856_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2026.110856_bib3","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1016\/j.bmc.2013.06.065","article-title":"Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors","volume":"21","author":"Alpan","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib4","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":"Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils","volume":"18","author":"Alvarez","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer's disease facts and figures","volume":"15","author":"Association","year":"2019","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110856_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/jmf.2009.1278","article-title":"Curcumin exerts neuroprotective effects against homocysteine intracerebroventricular injection-induced cognitive impairment and oxidative stress in rat brain","volume":"13","author":"Ataie","year":"2010","journal-title":"J. Med. Food"},{"key":"10.1016\/j.neuropharm.2026.110856_bib7","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.fct.2007.06.006","article-title":"Cassava starch fermentation wastewater: characterization and preliminary toxicological studies","volume":"45","author":"Avancini","year":"2007","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11011-015-9755-0","article-title":"Carnosine and taurine treatments diminished brain oxidative stress and apoptosis in D-galactose aging model","volume":"31","author":"Ayd\u0131n","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2026.110856_bib9","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1007\/s12035-016-9693-9","article-title":"The effects of inhaled Pimpinella peregrina essential oil on scopolamine-induced memory impairment, anxiety, and depression in laboratory rats","volume":"53","author":"Aydin","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031273","article-title":"The cholinergic system, the adrenergic system and the neuropathology of Alzheimer's disease","volume":"22","author":"Bekdash","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-8741(00)00309-3","article-title":"Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum","volume":"74","author":"Bhattacharya","year":"2001","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/oxfordjournals.bmb.a072188","article-title":"Free radicals in biological systems--a review orientated to inflammatory processes","volume":"43","author":"Blake","year":"1987","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.neuropharm.2026.110856_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1021694307672","article-title":"Differences in measures of exploration and fear in MHC-congenic C57BL\/6J and B6-H-2K mice","volume":"29","author":"Brown","year":"1999","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2026.110856_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087228","article-title":"Aluminium in the human brain: routes of penetration, toxicity, and resulting complications","volume":"24","author":"Bryli\u0144ski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbr.2015.12.041","article-title":"Oral administration of d-galactose induces cognitive impairments and oxidative damage in rats","volume":"302","author":"Budni","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110856_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/85064","article-title":"BACE1 is the major beta-secretase for generation of Abeta peptides by neurons","volume":"4","author":"Cai","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/14756366.2018.1458030","article-title":"Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues","volume":"33","author":"Caliandro","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-1-8","article-title":"Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family","volume":"1","author":"Cam","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.110856_bib19","article-title":"Neuroprotective evaluation of Tribulus terrestris L. in aluminum chloride induced Alzheimer's disease","volume":"32","author":"Chauhdary","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1039\/C5TX00464K","article-title":"Silver nanoparticles induced oxidative and endoplasmic reticulum stresses in mouse tissues: implications for the development of acute toxicity after intravenous administration","volume":"5","author":"Chen","year":"2016","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.neuropharm.2026.110856_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/760758","article-title":"Molecular targets in Alzheimer's disease: from pathogenesis to therapeutics","volume":"2015","author":"Cheng","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2026.110856_bib22","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.biopha.2018.04.152","article-title":"d-galactose and aluminium chloride induced rat model with cognitive impairments","volume":"103","author":"Chiroma","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.110856_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","article-title":"Alzheimer's disease drug development pipeline: 2018","volume":"4","author":"Cummings","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110856_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110856_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-017-0093-5","article-title":"Role of BACE1 in Alzheimer's synaptic function","volume":"6","author":"Das","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.110856_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1567205013666160930110551","article-title":"Targeting tumor necrosis factor alpha for Alzheimer's Disease","volume":"14","author":"Decourt","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2026.110856_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JAD-2007-11107","article-title":"Comparative effects of Abeta(1-42)-Al complex from rat and human amyloid on rat endothelial cell cultures","volume":"11","author":"Drago","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2026.110856_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-8223(00)00175-9","article-title":"Free galactose content of fresh fruits and strained fruit and vegetable baby foods: more foods to consider for the galactose-restricted diet","volume":"100","author":"Gropper","year":"2000","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.neuropharm.2026.110856_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/C8MD00472B","article-title":"ADMET-Score - a comprehensive scoring function for evaluation of chemical drug-likeness","volume":"10","author":"Guan","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.neuropharm.2026.110856_bib31","first-page":"858","article-title":"OECD guideline for the testing of chemicals","volume":"601","author":"Guideline","year":"2001","journal-title":"The Hershberger"},{"key":"10.1016\/j.neuropharm.2026.110856_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jscs.2019.03.002","article-title":"Unsymmetrically substituted benzimidazolium based Silver(I)-N-heterocyclic carbene complexes: synthesis, characterization and in vitro anticancer study against human breast cancer and Colon cancer","volume":"23","author":"Habib","year":"2019","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.neuropharm.2026.110856_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227631","article-title":"Naringenin protects AlCl3\/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress","volume":"15","author":"Haider","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.110856_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2015.01.016","article-title":"A high dose of short term exogenous D-galactose administration in young Male rats produces symptoms simulating the natural aging process","volume":"124","author":"Haider","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.brainresbull.2016.10.002","article-title":"Scopolamine-induced greater alterations in neurochemical profile and increased oxidative stress demonstrated a better model of dementia: a comparative study","volume":"127","author":"Haider","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.110856_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2018.02.023","article-title":"Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease","volume":"148","author":"Hiremathad","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brainres.2006.10.085","article-title":"Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats","volume":"1130","author":"Hrnkova","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110856_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12974-018-1376-1","article-title":"Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?","volume":"15","author":"Italiani","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110856_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5455\/oams.130412.or.004","article-title":"Silymarin and naringenin protects nicotine induced oxidative stress in young rats","volume":"1","author":"Jain","year":"2012","journal-title":"Oxidants and Antioxidants in Medical Science"},{"key":"10.1016\/j.neuropharm.2026.110856_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-publhealth-040218-043758","article-title":"Causes and patterns of dementia: an update in the era of redefining Alzheimer's Disease","volume":"40","author":"James","year":"2019","journal-title":"Annu. Rev. Publ. Health"},{"key":"10.1016\/j.neuropharm.2026.110856_bib41","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s10072-013-1444-3","article-title":"Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer's type (SDAT) caused by intracerebroventricular streptozotocin in rats","volume":"34","author":"Javed","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib42","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s11064-015-1525-1","article-title":"Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer's disease in Wistar rats","volume":"40","author":"Justin Thenmozhi","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.110856_bib43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/1028415X.2016.1144846","article-title":"Hesperidin ameliorates cognitive dysfunction, oxidative stress and apoptosis against aluminium chloride induced rat model of Alzheimer's disease","volume":"20","author":"Justin Thenmozhi","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib44","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.jinorgbio.2005.06.015","article-title":"Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions","volume":"99","author":"Kaizer","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib45","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuint.2012.07.025","article-title":"Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model","volume":"61","author":"Khan","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.110856_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-Maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12011-015-0229-3","article-title":"Protective effect of selenium against aluminum chloride-induced Alzheimer's disease: behavioral and biochemical alterations in rats","volume":"165","author":"Lakshmi","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.neuropharm.2026.110856_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12011-015-0229-3","article-title":"Protective effect of selenium against Aluminum chloride-induced alzheimer's disease: behavioral and biochemical alterations in rats","volume":"165","author":"Lakshmi","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.neuropharm.2026.110856_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1423-0127-19-32","article-title":"Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha","volume":"19","author":"Li","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib50","first-page":"647","article-title":"Development of AD like symptoms following co-administration of AlCl3 and D-gal in rats: a neurochemical, biochemical and behavioural study","volume":"30","author":"Liaquat","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lfs.2017.12.034","article-title":"Naringenin-induced enhanced antioxidant defence system meliorates cholinergic neurotransmission and consolidates memory in Male rats","volume":"194","author":"Liaquat","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neulet.2008.05.070","article-title":"Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin","volume":"440","author":"Lin","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.110856_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2026.110856_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2026.110856_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111572","article-title":"The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease","volume":"181","author":"Mesiti","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2026.110856_bib57","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib58","series-title":"EFFECT OF LONG TERM ADMINISTRATION OF ALUMINIUM CHLORIDE ON OXIDATIVE STRESS AND ACETYLCHOLINESTERASE ACTIVITY IN RAT BRAINS","author":"Naidu","year":"2013"},{"key":"10.1016\/j.neuropharm.2026.110856_bib59","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00204-014-1401-9","article-title":"Glutathione and mitochondria determine acute defense responses and adaptive processes in cadmium-induced oxidative stress and toxicity of the kidney","volume":"89","author":"Nair","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib60","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/acsinfecdis.8b00279","article-title":"Antimalarial Pyrido[1,2- a]benzimidazole derivatives with mannich base side chains: synthesis, pharmacological evaluation, and reactive metabolite trapping studies","volume":"5","author":"Okombo","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.neuropharm.2026.110856_bib61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acschemneuro.8b00069","article-title":"Alzheimer's Disease, the \"One-Molecule, One-Target\" Ppradigm, and the Mmltitarget Ddrected Llgand Aaproach","volume":"9","author":"Oset-Gasque","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bioorg.2017.04.018","article-title":"Novel multi-targeted agents for Alzheimer's disease: synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles","volume":"72","author":"Ozadali-Sari","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/rej.2010.1020","article-title":"D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice","volume":"13","author":"Parameshwaran","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.neuropharm.2026.110856_bib64","first-page":"37","article-title":"Swim everyday to keep dementia away","volume":"4","author":"Parle","year":"2005","journal-title":"J. Sports Sci. Med."},{"key":"10.1016\/j.neuropharm.2026.110856_bib65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/9789811401893119080004","article-title":"The therapy of Alzheimer's disease: towards a new generation of drugs","volume":"8","author":"Piemontese","year":"2019","journal-title":"Front. Clin. Drug Res. Alzheimer Disord"},{"key":"10.1016\/j.neuropharm.2026.110856_bib66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejphar.2017.11.012","article-title":"Very low doses of muscimol and baclofen ameliorate cognitive deficits and regulate protein expression in the brain of a rat model of streptozocin-induced Alzheimer's disease","volume":"818","author":"Pilipenko","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt220","article-title":"Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future","volume":"5","author":"Prins","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuropharm.2026.110856_bib68","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.physbeh.2015.11.016","article-title":"Protective effect of tetrahydropalmatine against d-galactose induced memory impairment in rat","volume":"154","author":"Qu","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.110856_bib69","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1007\/s12035-016-9981-4","article-title":"D-Galactose causes motor coordination impairment, and histological and biochemical changes in the cerebellum of rats","volume":"54","author":"Rodrigues","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejmech.2015.01.060","article-title":"Synthesis and biological evaluation of pyridazino[1',6':1,2]pyrido[3,4-b]indolinium and pyridazino[1,6-a]benzimidazolium salts as anti-inflammatory agents","volume":"93","author":"Rodr\u00edguez-Sanz","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib71","first-page":"136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease","volume":"50","author":"Rogers","year":"1998","journal-title":"Donepezil Study Group. Neurology"},{"key":"10.1016\/j.neuropharm.2026.110856_bib72","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.toxrep.2017.10.005","article-title":"Acute oral toxicity evaluation of aqueous ethanolic extract of Saccharum munja Roxb. Roots in albino mice as per OECD 425 TG","volume":"4","author":"Saleem","year":"2017","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.neuropharm.2026.110856_bib73","article-title":"Experimental and computational studies to characterize and evaluate the therapeutic effect of Albizia lebbeck (L.) seeds in Alzheimer's Disease","volume":"55","author":"Saleem","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.neuropharm.2026.110856_bib74","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bioorg.2018.11.010","article-title":"Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-alzheimer's agents","volume":"83","author":"Salehi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/ph16050753","article-title":"Dapagliflozin ameliorates cognitive impairment in aluminum-chloride-induced alzheimer's disease via modulation of AMPK\/mTOR, oxidative stress and glucose metabolism","volume":"16","author":"Samman","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2026.110856_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800076","article-title":"Multifunctional cholinesterase inhibitors for Alzheimer's disease: synthesis, biological evaluations, and docking studies of o\/p-propoxyphenylsubstituted-1H-benzimidazole derivatives","author":"Sar\u0131kaya","year":"2018","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.neuropharm.2026.110856_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2020.119462","article-title":"Benzimidazolium-acridine-based silver N-heterocyclic carbene complexes as potential anti-bacterial and anti-cancer drug","volume":"504","author":"Sharhan","year":"2020","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.neuropharm.2026.110856_bib78","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bmc.2016.11.009","article-title":"Synthesis, anti-proliferative activity, SAR study, and preliminary in vivo toxicity study of substituted N,N'-bis(arylmethyl)benzimidazolium salts against a panel of non-small cell lung cancer cell lines","volume":"25","author":"Shelton","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib79","first-page":"532","article-title":"TRIzol: a new reagent for optimal single-step isolation of RNA","volume":"15","author":"Simms","year":"1993","journal-title":"Focus"},{"key":"10.1016\/j.neuropharm.2026.110856_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118759","article-title":"Environmental aluminum exposure and Alzheimer's disease risk: evidence from a systematic review and meta-analysis","volume":"302","author":"Soleimani","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.neuropharm.2026.110856_bib81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11357-009-9099-y","article-title":"Alteration of A\u03b2 metabolism-related molecules in predementia induced by AlCl3 and D-galactose","volume":"31","author":"Sun","year":"2009","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.neuropharm.2026.110856_bib82","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-4159.2007.05072.x","article-title":"Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein","volume":"104","author":"Tamagno","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110856_bib83","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3233\/JAD-140843","article-title":"Biomarkers for preclinical Alzheimer's disease","volume":"42","author":"Tan","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2026.110856_bib84","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jep.2006.03.023","article-title":"Acute and subacute toxicity study of the ethanol extract from Lonicera japonica Thunb","volume":"107","author":"Thanabhorn","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib85","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0270(02)00360-6","article-title":"Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism","volume":"123","author":"Tillerson","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2026.110856_bib86","series-title":"AVMA Guidelines for the Euthanasia of Animals","first-page":"2020","author":"Underwood","year":"2020"},{"key":"10.1016\/j.neuropharm.2026.110856_bib87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3923\/jpt.2011.113.123","article-title":"Acute oral toxicity study of Pluchea arguta boiss extract in mice","volume":"6","author":"Vaghasiya","year":"2011","journal-title":"J. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib88","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yrtph.2018.11.010","article-title":"Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice","volume":"101","author":"Variya","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110856_bib89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuroscience.2017.04.050","article-title":"Chitinase1 contributed to a potential protection via microglia polarization and A\u03b2 oligomer reduction in D-galactose and aluminum-induced rat model with cognitive impairments","volume":"355","author":"Xiao","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110856_bib90","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1039\/D4SC06762B","article-title":"Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-\u03b2 aggregation, metal ion homeostasis, and enzyme inhibition","volume":"16","author":"Yoo","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.neuropharm.2026.110856_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1749-8104-3-15","article-title":"Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1","volume":"3","author":"Young-Pearse","year":"2008","journal-title":"Neural Dev."},{"key":"10.1016\/j.neuropharm.2026.110856_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.137069","article-title":"Fluoxastrobin-induced effects on acute toxicity, development toxicity, oxidative stress, and DNA damage in Danio rerio embryos","volume":"715","author":"Zhang","year":"2020","journal-title":"Sci. Total Environ."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:59:09Z","timestamp":1779004749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":92,"alternative-id":["S0028390826000298"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110856","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel IMS48 as a dual inhibitor of acetylcholinesterase and butyrylcholinesterase: In vitro and in vivo study for Alzheimer therapy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110856"}}